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2 
Abstract 1 
 2 
Background: Reduction in arterial compliance with aging increases the risk of 3 
cardiovascular disease. Lifestyle modification, particularly aerobic exercise and dietary 4 
modification, has a favorable effect on vascular aging. Curcumin, a major component of 5 
turmeric, is an anti-inflammatory agent. Therefore, it is plausible to hypothesize that 6 
curcumin improves arterial compliance. We investigated the effects of curcumin ingestion 7 
alone and in combination with aerobic exercise training on arterial compliance in 8 
postmenopausal women.  9 
Methods: A total of 51 postmenopausal women were assigned to 4 groups: placebo, 10 
curcumin, exercise and placebo (Ex + placebo), and exercise and curcumin (Ex + curcumin). 11 
Curcumin or placebo was ingested orally for 8 weeks. The exercise groups underwent 12 
moderate aerobic exercise training for 8 weeks.  13 
Results: Carotid arterial compliance increased significantly in the curcumin, Ex + placebo, 14 
and Ex + curcumin groups, whereas no such changes were observed in the placebo control 15 
group. The magnitude of increases in carotid arterial compliance was the greatest in the Ex + 16 
curcumin group.  17 
Conclusion: We concluded that curcumin ingestion improves carotid arterial compliance and 18 
that the combination of curcumin and aerobic exercise training was more efficacious in 19 
increasing central arterial compliance than either of these treatments alone in postmenopausal 20 
women. 21 
 22 
Keywords: arterial stiffness, lifestyle modification, physical activity, turmeric 23 
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Introduction 1 
The large elastic arteries, such as the common carotid artery and the aorta, have the 2 
ability to buffer and cushion oscillation in blood pressure and blood flow.1 This compliant 3 
function of central arteries decreases with advancing age.2-3 Reduction in central arterial 4 
elasticity is an independent risk factor for cardiovascular disease.4 In addition, although 5 
arterial compliance in premenopausal women is greater than in age-matched men, this 6 
difference is lost in postmenopausal years,5-6 which suggests that postmenopausal women are 7 
at a higher risk of cardiovascular disease.7-8 We have previously demonstrated that regular 8 
aerobic exercise is clinically efficacious in preventing and treating decreased arterial 9 
compliance.9-10 Thus, it is therefore preferable to treat or prevent a decrease in arterial 10 
compliance without pharmacological therapies, e.g., lifestyle modification including exercise 11 
and/or diet. 12 
 13 
Recent studies suggest that impairment of the arterial elastic properties is associated 14 
with chronic inflammatory disorders.11-12 Vlachopoulos et al.13 reported that acute systemic 15 
inflammation leads to deterioration of the central artery. Therefore, it is plausible that central 16 
arterial compliance improves with the aid of an anti-inflammatory agent. Curcumin is a 17 
polyphenolic molecule extracted from turmeric.14 Curcumin regulates various biochemical 18 
and molecular pathway by modulating several molecular targets, including transcription 19 
factors, cytolkines, enzymes, and gene regulating cell proliferation and apoptosis.15 As a 20 
results, curcumin has been shown to exert anti-inflammatory activity by binding to directly to 21 
pro-inflammatory molecules.15 Furthermore, it has been reported that curcumin may have 22 
protective effects against cardiovascular disease.16 However, the effect of curcumin ingestion 23 
on arterial compliance is unknown. Furthermore, although it is well known that aerobic 24 
exercise improves arterial compliance,3,9,10 the combined effect of exercise training and 25 
curcumin on arterial compliance has never been investigated. 26 
 27 
The purpose of this study was to determine effects of curcumin ingestion alone and 28 
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in combination with aerobic exercise training on central arterial compliance in 1 
postmenopausal women. We hypothesized that curcumin ingestion increases arterial 2 
compliance and the combination of curcumin and exercise training is more efficacious in 3 
increasing arterial compliance than either treatment alone. To test these hypotheses, we used 4 
a placebo-controlled study involving apparently healthy postmenopausal women. 5 
 6 
Methods 7 
Subjects.  8 
A total of 51 healthy, sedentary postmenopausal women volunteered to participate. Subjects 9 
were assigned randomly to one of the following intervention groups: placebo group (n = 12), 10 
curcumin group (n = 12), exercise training with placebo group (Ex + placebo; n = 13), and 11 
exercise training with curcumin group (Ex + curcumin; n = 14). Subjects were nonsmokers, 12 
nonobese, and free of cardiovascular disease as assessed by medical history. None of the 13 
subjects were taking cardiovascular-acting medications. All subjects gave their written 14 
informed consent to participate. All procedures were reviewed and approved by the ethical 15 
committee of the University of Tsukuba. 16 
 17 
Experimental design.  18 
All experiments proceeded in the morning after a 12-h overnight fast. Subjects abstained 19 
from alcohol and caffeine for at least 12 h and did not exercise for at least 24 h before 20 
beginning the experiment to avoid the potential acute effects of exercise. Measurements were 21 
taken in a quiet, temperature-controlled room (24–26°C). After a resting period of at least 20 22 
min, carotid arterial compliance, intima-media thickness (IMT), arterial blood pressure, and 23 
blood biochemistry were determined. After these measurements, peak oxygen consumption 24 
(V
．
O2peak) was measured during incremental cycle ergometer exercise. These parameters were 25 
measured before and after each intervention. 26 
 27 
Curcumin ingestion.  28 
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Subjects in the curcumin and Ex + curcumin groups ingested 150 mg of curcumin 1 
(Theracurumin, Theravalues Corporation, Tokyo) per day divided into 6 capsules. The 2 
capsule with only starch (e.g., dextrin and maltose) was used as a placebo. Each subjects in 3 
the placebo and Ex + placebo groups ingested 6 placebo capsules. Curcumin or placebo was 4 
administered orally for 8 weeks. All subjects were instructed not to alter their dietary habits 5 
during the intervention period. 6 
 7 
Exercise intervention.  8 
Subjects in the Ex + placebo and Ex + curcumin groups underwent aerobic exercise training 9 
more than 3 days per week (2–3 supervised sessions and additional home-based training) for 10 
8 weeks as previously described.10 Initially, subjects performed cycling and walking 30 11 
min/day at a relatively low intensity (60% of their individually determined maximal heart rate, 12 
which was evaluated by the maximal cycle exercise test). As their exercise tolerance 13 
improved, the intensity and time of aerobic exercise were increased to 40–60 min/day at an 14 
intensity of 70–75 % of the maximal heart rate. Heart rate during exercise was evaluated by a 15 
digital pulse rate monitor (SM-66; Skynie, Tokyo, Japan). Subjects recorded their actual 16 
exercise and any additional physical activity on diary basis. Adherence to the exercise 17 
prescription was documented through the use of a uniaxial electrical accerometer (Lifecorder; 18 
KENZ, Nagoya, Japan) and physical activity logs as described previously.17 Subjects in the 19 
placebo and curcumin groups were instructed not to change their level of physical activity. 20 
 21 
Measurements 22 
Carotid Arterial Compliance. Carotid arterial compliance was determined using a 23 
combination of ultrasound imaging and simultaneous applanation tonometry of the common 24 
carotid artery. The common carotid artery was imaged B-mode using ultrasound (En Visor; 25 
Koinklijke Philips Electronics, Eindhoven, The Netherland) equipped with a high-resolution 26 
linear-array transducer (7.5 Hz). Diameters were measured from the intima of the far wall to 27 
the media-adventitia of the near wall. Pulsatile changes in the common carotid artery 28 
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diameter were analyzed 1 to 2 cm proximal to the bifurcation. Carotid arterial pressure 1 
waveforms were obtained with arterial applanation tonometry incorporating an array of 15 2 
micropiezoresistive transducers (FormPWV/ABI; Colin Medical Technology, Komaki, 3 
Japan),18 and were calibrated by equating the carotid mean arterial and diastolic blood 4 
pressure to the brachial mean arterial and diastolic blood pressure. The arterial lumen 5 
diameter at minimal diastolic relaxation and maximal systolic expansion of the vessel was 6 
measured at 3 points per frame and then averaged. Each parameter was averaged over 10–15 7 
continuous beats and statistically analyzed. Arterial compliance was obtained using the 8 
following equation: 9 
 [(D1 – D0)/D0]/[2(P1 – P0)πD0] 10 
where D1 and D0 are the maximal and minimum arterial diameters, and P1 and P0 are the 11 
highest and lowest blood pressures respectively. In addition to arterial compliance, the 12 
β-stiffness index was analyzed using the following equation: 13 
ln(P1/P0)/[(D1 − D0)/D0] 14 
The β-stiffness index provided an index of arterial compliance adjusted for distending 15 
pressure.19 16 
 17 
Carotid Artery Intima-Media Thickness. Carotid artery IMT was measured from the images 18 
derived from the same ultrasound machine (En Visor; Koinklijke Philips Electronics, 19 
Eindhoven, The Netherland) as previously described.20 Carotid IMT was defined as distance 20 
from the leading edge of the lumen-intima interface. Lumen diameter was defined as the 21 
distance between the lumen and intima, and a near-wall boundary, corresponding to the 22 
interface of the adventitia and media. These measurements were made at end diastole. At 23 
least 10 measurements of IMT were taken at each segment, and the mean values were used 24 
for analysis. 25 
 26 
Blood Chemistry. A blood sample was collected from the antecubital vein after overnight 27 
fasting. Serum concentrations of cholesterol and triglyceride were determined using standard 28 
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7 
enzymatic techniques. 1 
 2 
Peak Oxygen Consumption. V
．
O2peak was measured during incremental cycle ergometer 3 
exercise by using online computer-assisted circuit spirometry (AE280; Minato Medical 4 
Science, Osaka, Japan). All subjects underwent an incremental exercise test (after 2 min at 40 5 
W, with 20 W increases every 2 min) until volitional exhaustion. V
．
O2peak was defined at the 6 
highest value recorded during the test. Heart rate and rating of perceived exertion21 were 7 
measured throughout the exercise, and the total exercise duration required to reach 8 
exhaustion was recorded. 9 
 10 
Statistical analyses 11 
To determine the effect of each intervention on all outcome measures, repeated measures 12 
analysis of variance was used. When indicated by a significant main effect on intervention, 13 
specific mean comparisons were performed to identify significant within each intervention. In 14 
the case of a significant F-value, a post-hoc test (the Bonferroni test) was used to identify 15 
significant differences among mean values. All data are reported as means ± SE. Statistical 16 
significant was set a priori at P < 0.05 for all comparisons. 17 
 18 
Results 19 
In the exercise groups (Ex + placebo and Ex + curcumin), the average frequency and 20 
time of the exercise training were similar. The average frequency of the exercise training was 21 
4.7 ± 0.3 days/week (Ex + placebo) and 4.9 ± 0.3 days/week (Ex + curcumin) (p=0.776), and 22 
the average time of the exercise training was 43.0 ± 1.6 min/day (Ex + placebo) and 49.5 ± 23 
3.8 min/day (Ex + curcumin) (p=0.136). There were no significant differences in 24 
compliance/adherence to the placebo and curcumin ingestion regimen between the 4 groups 25 
(95% ± 3% in placebo; 99% ± 1% in curcumin; 98% ± 1% in Ex + placebo; 98% ± 1% in Ex 26 
+ curcumin). 27 
 28 
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Table 1 shows the baseline characteristics of the study participants. Before the 1 
intervention, there were no significant differences in any of the variables among groups. 2 
Body weight and body mass index decreased in the Ex + curcumin group (P < 0.05). 3 
High-density lipoprotein cholesterol increased significantly after the intervention in the Ex + 4 
placebo group (P < 0.05). There were no significant changes in low-density lipoprotein 5 
cholesterol and triglyceride level with any of the intervention. Absolute and relative V
．
O2peak 6 
in the exercise groups (both Ex + placebo and Ex + curcumin groups) increased significantly 7 
after the intervention (P < 0.05).  8 
 9 
As shown in Table 2, there were no statistically significant differences in the 10 
baseline hemodynamic parameters at rest among the groups before intervention. Heart rate 11 
did not change in any of the group. After 8weeks of intervention, brachial and carotid systolic 12 
blood pressure decreased in the curcumin, Ex + placebo, and Ex + curcumin groups (P < 13 
0.05). Brachial diastolic blood pressure significantly decreased in the Ex + curcumin group (P 14 
< 0.05). Brachial pulse pressure significantly decreased in the Ex + placebo group (P < 0.05). 15 
IMT did not change before and after each intervention in all groups. Carotid pulse pressure 16 
and ß-stiffness index significantly decreased in the Ex + placebo and Ex + curcumin groups 17 
(P < 0.05).  18 
 19 
There was no significant difference in the baseline carotid arterial compliance 20 
among the groups (Fig. 1). After 8 weeks of intervention, carotid arterial compliance 21 
increased significantly in the curcumin, Ex + placebo, and Ex + curcumin groups. There was 22 
no significant change in carotid arterial compliance in the placebo control group. The percent 23 
change in carotid arterial compliance was significantly greater in the Ex + curcumin group 24 
than in the placebo group (Fig. 2). On the other hand, the percent change in the curcumin 25 
group or the Ex + placebo group statistically did not differ compared with the placebo group 26 
(Fig. 2). 27 
 28 
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Discussion 1 
The main findings of the present investigation were as follows. A regular ingestion 2 
of curcumin significantly increased carotid arterial compliance in postmenopausal women. 3 
The magnitude of improvement by curcumin was similar to that of exercise training alone. 4 
Moreover, the combination of exercise training and curcumin ingestion led to a greater 5 
improvement in arterial compliance compared to that achived with either treatment alone. 6 
These results suggest that a combination of exercise and curcumin can have a strong positive 7 
effect on arterial compliance. 8 
 9 
Curcumin is a perennial herb that is widely cultivated in Asia and is commonly used 10 
as a spice to add flavor and yellow, coloring to food. Curcumin is known to 11 
anti-inflammatory effects in addition to acting as an anti-carcinogenic and neuroprotective 12 
agent.22-24 To our knowledge, the effects of curcumin an arterial compliance have never been 13 
studied. In the present study, we revealed for the first time that central arterial compliance 14 
increased after 8 weeks of the curcumin ingestion in postmenopausal women. Furthermore, 15 
the magnitude of improvement achieved by curcumin treatment was comparable to that 16 
obtained with exercise treatment (10.1% ± 4.5% vs. 10.0% ± 3.6%). This finding suggests 17 
that the favorable effect of curcumin can be a primary therapeutic approach for 18 
cardiovascular disease in postmenopausal women. 19 
 20 
In our previous study, we investigated the effect of exercise training and curcumin 21 
ingestion on central arterial hemodynamics, i.e., wave reflection and central blood pressure.25 22 
Wave reflection and central blood pressure were not improved by exercise training alone or 23 
curcumin ingestion alone. These parameters improved in the combined exercise training with 24 
curcumin ingestion. On the other hand, the present study investigated the effect of curcumin 25 
on arterial compliance. We demonstrated for the first time that curcumin ingestion alone 26 
increased arterial compliance. In addition, the magnitude of increase in carotid arterial 27 
compliance was the greatest in the Ex + curcumin group among 4 groups. Therefore, these 28 
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results suggest that the combination of exercise and curcumin may more effectively increase 1 
arterial compliance than either treatment alone, although curcumin ingestion alone or exercise 2 
training alone increased arterial compliance. 3 
 4 
The mechanism responsible for the curcumin ingestion induced improvement in 5 
arterial compliance is unclear in this study. Arterial elastic property is associated with 6 
inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α).12 Curcumin exerts 7 
anti-inflammatory effects by inhibiting the expression of cytokines including TNF-α.26 8 
Therefore, the effect of curcumin on arterial compliance may be mediated by suppression of 9 
inflammation via downregulating of TNF-α. However, we did not measure any inflammatiory 10 
cytokines in this study. Further studies are warranted to clarify the mechanism underlying the 11 
effect of curcumin on arterial compliance. 12 
 13 
Most measures of arterial compliance are somewhat dependent on arterial pressure. 14 
It is possible that the improvement in the arterial compliance by our treatment of curcumin 15 
ingestion and exercise training may be mediated by the corresponding changes in arterial 16 
blood pressure. To address this possibility, we calculated the β-stiffness index of arterial 17 
compliance adjusted for distending pressure. The results indicated that improvement in 18 
arterial compliance after the exercise intervention remained statistically significant even 19 
when the data were expressed as the β-stiffness index. However, the change in the β-stiffness 20 
index after curcumin intervention did not attain statistical significance. Thus, the 21 
improvement in arterial compliance with curcumin may be effected partly by the 22 
epiphenomenon of blood pressure change. 23 
 24 
We observed that the greatest change in arterial compliance was achieved with a 25 
combination of curcumin ingestion and exercise training. This result may be attributable to 26 
physiological mechanism by which exercise training and curcumin increase arterial 27 
compliance. Aerobic exercise training results in a decrease in of endothelin-1 production27 28 
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and α-adrenergic vasoconstrictor tone.28 To the best of our knowledge, there have been no 1 
reports that curcumin positively influence these mechanisms. Therefore, curcumin and 2 
exercise training are likely to have different physiological mechanisms to improve the elastic 3 
property of the large artery. This may be the reason why combining exercise training with 4 
curcumin ingestion appears more effective than a single intervention. 5 
 6 
It is unclear that body weight and BMI decrease only in the Ex + curcumin group. 7 
Little is known to the effect of curcumin on body composition. An animal study suggests that 8 
curcumin increases fatty acid oxidation and reduces fatty acid esterification, resulting in 9 
catabolism in adipose tissue and body weight reduction in obese mice.29 However, our 10 
present study was not observed weight and BMI reduction by curcumin supplementation 11 
alone in postmenopausal women. Exercise training alone also did not decrease body weight 12 
and BMI. On the other hand, the combination of exercise training with curcumin ingestion 13 
decreases body weight and BMI. It is possible that fatty acid oxidation is promoted by the 14 
combination of curcumin ingestion and exercise training in postmenopausal women. 15 
 16 
In conclusion, the present study demonstrated that curcumin ingestion alone 17 
increases arterial compliance in postmenopausal women and that combining curcumin 18 
ingestion with aerobic exercise training more effectively increases arterial compliance than 19 
curcumin ingestion or aerobic exercise training alone. Regular curcumin ingestion and 20 
aerobic exercise may be effective lifestyle modifications for minimizing and reversing the 21 
loss of carotid arterial compliance with advancing age in women. 22 
 23 
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Figure legends 1 
Figure.1 Carotid arterial compliance before and after intervention. Data are expressed 2 
as mean ± SE. *P < 0.05 before vs. after intervention. 3 
 4 
Figure.2 Percent changes in arterial compliance in response to intervention. Data are 5 
expressed as mean ± SE. *P < 0.05 placebo vs. exercise + curcumin (Ex + curcumin). 6 
 7 
  8 
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Table 1. Selected subject characteristics 
Values are means ± SE. HDL; high density lipoprotein, LDL; low density lipoprotein, V
．
O2peak; peak oxygen 
consumption. *P < 0.05 vs. before intervention. 
 
 
    Placebo   Curcumin   Ex+placebo   Ex+Curcumin 
Age, years Before 58  ± 1   60  ± 2   59  ± 2   60  ± 1  
                 
Height, cm Before 156  ± 2   155  ± 2   154  ± 1   157  ± 1  
                 
Weight, kg Before 52.1  ± 1.9   52.6  ± 2.5   52.2  ± 1.5   56.6  ± 1.8  
 After 52.3  ± 1.8   52.7  ± 2.5   52.1  ± 1.5   55.6  ± 1.5* 
                 
Body mass index, kg/m2 Before 21.5  ± 0.8   21.9  ± 0.7   22.1  ± 0.5   23.2  ± 1.8  
 After 21.6  ± 0.7   22.0  ± 0.7   22.1  ± 0.6   22.7  ± 0.8* 
                 
HDL cholesterol, mmol/L Before 1.73  ± 0.11   1.58  ± 0.13   1.69  ± 0.07   1.78  ± 0.10  
 After 1.81  ± 0.12   1.61  ± 0.13   1.85  ± 0.08*  1.89  ± 0.12  
                 
LDL cholesterol, mmol/L Before 3.45  ± 0.12   3.65  ± 0.21   3.56  ± 0.19   3.64  ± 0.15  
 After 3.42  ± 0.10   3.98  ± 0.20   3.57  ± 0.18   3.74  ± 0.19  
                 
Triglyceride, mmol/L Before 1.15  ± 0.15   1.66  ± 0.29   1.16  ± 0.11   1.15  ± 0.13  
 After 1.24  ± 0.15   1.56  ± 0.32   0.99  ± 0.12   1.16  ± 0.18  
                 
V
．
O2peak, ml/min Before 1312 ± 78  1179 ± 58  1282 ± 66  1390 ± 79 
 After 1221 ± 56  1175 ± 62  1394 ± 73*  1474 ± 82* 
                 
V
．
O2peak, ml/kg/min Before 25.6  ± 2.0   22.6  ± 0.9   24.7  ± 1.2   24.5  ± 1.2  
  After 23.5  ± 1.2    22.4  ± 0.8    26.9  ± 1.4*   26.5  ± 1.2* 
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Table 2. Hemodynamic parameter before and after intervention 
    Placebo   Curcumin   Ex + placebo   Ex + Curcumin 
Heart rate, beats/min Before 64  ± 3  61  ± 2   59  ± 1  60  ± 2  
 After 62  ± 2  59  ± 2   57  ± 1  57  ± 1  
                 
Brachial SBP, mmHg Before 114  ± 4  123  ± 5   112  ± 3  118  ± 4  
 After 114  ± 4  119  ± 4*  108  ± 3*  113  ± 4* 
                 
Brachial DBP, mmHg Before 71  ± 3  72  ± 4  69  ± 2  71  ± 3  
 After 71  ± 3  69  ± 3  68  ± 2  67  ± 3* 
                 
Brachial PP, mmHg Before 42  ± 2  51  ± 2  43  ± 3  47  ± 2 
 After 43  ± 2  50  ± 2  40  ± 2*  45  ± 2 
                 
Caroid SBP, mmHg Before 103  ± 3  112  ± 5  103  ± 3  107  ± 4 
 After 104  ± 3  108  ± 4*  99  ± 3*  102  ± 4* 
                 
Carotid PP, mmHg Before 32  ± 2  40  ± 2  34  ± 3  37  ± 2 
 After 33  ± 2  39  ± 2  32  ± 2*  35  ± 2* 
                 
IMT, mm Before 0.53 ± 0.01  0.55 ± 0.03  0.55 ± 0.03  0.52 ± 0.02 
 After 0.53 ± 0.01  0.55 ± 0.03  0.54 ± 0.03  0.52 ± 0.02 
                 
β-stiiffness, U Before 7.6  ± 0.4   7.8  ± 0.6   8.3  ± 0.6   8.0  ± 0.5  
  After 7.9  ± 0.4    7.4  ± 0.4    7.5  ± 0.5*   7.2  ± 0.4* 
Values are means ± SE. SBP; systolic blood pressure, DBP; diastolic blood pressure, PP; pulse pressure, 
IMT; intima-media thickness. *P < 0.05 vs. before intervention. 
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